Literature DB >> 21622984

Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).

Limei Xu1, Darin Salloum, Phil S Medlin, Mahesh Saqcena, Paige Yellen, Benjamin Perrella, David A Foster.   

Abstract

The mammalian target of rapamycin (mTOR) is a critical sensor of nutritional sufficiency. Although much is known about the regulation of mTOR in response to growth factors, much less is known about the regulation of mTOR in response to nutrients. Amino acids have no impact on the signals that regulate Rheb, a GTPase required for the activation of mTOR complex 1 (mTORC1). Phospholipase D (PLD) generates a metabolite, phosphatidic acid, that facilitates association between mTOR and the mTORC1 co-factor Raptor. We report here that elevated PLD activity in human cancer cells is dependent on both amino acids and glucose and that amino acid- and glucose-induced increases in mTORC1 activity are dependent on PLD. Amino acid- and glucose-induced PLD and mTORC1 activity were also dependent on the GTPases RalA and ARF6 and the type III phosphatidylinositol-3-kinase hVps34. Thus, a key stimulatory event for mTORC1 activation in response to nutrients is the generation of phosphatidic acid by PLD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622984      PMCID: PMC3138251          DOI: 10.1074/jbc.M111.249631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Phospholipase D structure and regulation.

Authors:  M A Frohman; A J Morris
Journal:  Chem Phys Lipids       Date:  1999-04       Impact factor: 3.329

2.  RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1.

Authors:  J Q Luo; X Liu; S M Hammond; W C Colley; L A Feig; M A Frohman; A J Morris; D A Foster
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

3.  hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.

Authors:  Maya P Byfield; James T Murray; Jonathan M Backer
Journal:  J Biol Chem       Date:  2005-07-27       Impact factor: 5.157

4.  The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.

Authors:  Ewan M Smith; Stephen G Finn; Andrew R Tee; Gareth J Browne; Christopher G Proud
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

Review 5.  The Akt-mTOR tango and its relevance to cancer.

Authors:  Nissim Hay
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

6.  Alternative phospholipase D/mTOR survival signal in human breast cancer cells.

Authors:  Yuhong Chen; Vanessa Rodrik; David A Foster
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

7.  Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.

Authors:  Xiaomeng Long; Sara Ortiz-Vega; Yenshou Lin; Joseph Avruch
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

8.  Functional association between Arf and RalA in active phospholipase D complex.

Authors:  J Q Luo; X Liu; P Frankel; T Rotunda; M Ramos; J Flom; H Jiang; L A Feig; A J Morris; R A Kahn; D A Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 9.  Targeting mTOR-mediated survival signals in anticancer therapeutic strategies.

Authors:  David A Foster
Journal:  Expert Rev Anticancer Ther       Date:  2004-08       Impact factor: 4.512

Review 10.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

View more
  52 in total

Review 1.  Ras family of small GTPases in immunity and inflammation.

Authors:  Derek S Johnson; Youhai H Chen
Journal:  Curr Opin Pharmacol       Date:  2012-03-07       Impact factor: 5.547

Review 2.  Regulation of TOR by small GTPases.

Authors:  Raúl V Durán; Michael N Hall
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

3.  Rag GTPases and AMPK/TSC2/Rheb mediate the differential regulation of mTORC1 signaling in response to alcohol and leucine.

Authors:  Ly Q Hong-Brown; C Randell Brown; Abid A Kazi; Maithili Navaratnarajah; Charles H Lang
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-21       Impact factor: 4.249

4.  Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.

Authors:  Chongben Zhang; Angela A Wendel; Matthew R Keogh; Thurl E Harris; Jie Chen; Rosalind A Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

5.  Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.

Authors:  Maria A Frias; Suman Mukhopadhyay; Elyssa Lehman; Aleksandra Walasek; Matthew Utter; Deepak Menon; David A Foster
Journal:  J Biol Chem       Date:  2019-11-24       Impact factor: 5.157

Review 6.  The Enigma of Rapamycin Dosage.

Authors:  Suman Mukhopadhyay; Maria A Frias; Amrita Chatterjee; Paige Yellen; David A Foster
Journal:  Mol Cancer Ther       Date:  2016-02-25       Impact factor: 6.261

Review 7.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

8.  Identification of the catalytic site of phospholipase D2 (PLD2) newly described guanine nucleotide exchange factor activity.

Authors:  Madhu Mahankali; Karen M Henkels; Gerald Alter; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 9.  Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Authors:  David A Foster; Darin Salloum; Deepak Menon; Maria A Frias
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

Review 10.  Functional regulation of phospholipase D expression in cancer and inflammation.

Authors:  Dong Woo Kang; Kang-Yell Choi; Do Sik Min
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.